GTN Stock Overview
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr15.77 |
| 52 Week High | kr20.85 |
| 52 Week Low | kr14.97 |
| Beta | 0.49 |
| 11 Month Change | -1.71% |
| 3 Month Change | -12.29% |
| 1 Year Change | 1.97% |
| 33 Year Change | -51.79% |
| 5 Year Change | 17.86% |
| Change since IPO | 44.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| GTN | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -4.1% | -3.5% | 0.09% |
| 1Y | 2.0% | -2.2% | 3.1% |
Return vs Industry: GTN exceeded the German Medical Equipment industry which returned -0.8% over the past year.
Return vs Market: GTN matched the German Market which returned 2.9% over the past year.
Price Volatility
| GTN volatility | |
|---|---|
| GTN Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: GTN's share price has been volatile over the past 3 months.
Volatility Over Time: GTN's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,862 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
| GTN fundamental statistics | |
|---|---|
| Market cap | €4.31b |
| Earnings (TTM) | €203.20m |
| Revenue (TTM) | €2.86b |
21.2x
P/E Ratio1.5x
P/S RatioIs GTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GTN income statement (TTM) | |
|---|---|
| Revenue | kr32.20b |
| Cost of Revenue | kr17.59b |
| Gross Profit | kr14.61b |
| Other Expenses | kr12.32b |
| Earnings | kr2.29b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 18, 2024
| Earnings per share (EPS) | 8.39 |
| Gross Margin | 45.37% |
| Net Profit Margin | 7.10% |
| Debt/Equity Ratio | 20.1% |
How did GTN perform over the long term?
See historical performance and comparison